Novome Biotechnologies Raises $43.5 Million Series B Financing to Advance its…
- Funding supports ongoing Phase 2a clinical trial in patients with enteric hyperoxaluria, and pipeline of GEMMs candidates for inflammatory bowel disease - - Financing includes new…